| 发明名称 |
Therapeutic use of a growth factor, METRNL |
| 摘要 |
The present invention relates to the field of therapeutic use of proteins, genes and cells, in particular to the therapy based on the biological function of a secreted therapeutic protein, METRNL, in particular for the treatment of disorders of the nervous system. METRNL is a Nerve Survival and Growth factor with neuroprotective and/or neurogenesis effects.
|
| 申请公布号 |
US8334264(B2) |
申请公布日期 |
2012.12.18 |
| 申请号 |
US20090936501 |
申请日期 |
2009.07.07 |
| 申请人 |
JOERGENSEN JESPER ROLAND;FJORD-LARSEN LONE;WAHLBERG LARS ULRIK;ANDRADE NUNO MIGUEL GOMES;JOHANSEN TEIT E.;NSGENEE A/S |
发明人 |
JOERGENSEN JESPER ROLAND;FJORD-LARSEN LONE;WAHLBERG LARS ULRIK;ANDRADE NUNO MIGUEL GOMES;JOHANSEN TEIT E. |
| 分类号 |
A01N37/18;C07K1/00;C07K14/00 |
主分类号 |
A01N37/18 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
